Drug Shortage Report for GAMMAGARD LIQUID

Last updated on 2020-02-06 History
Report ID 90434
Drug Identification Number 02279444
Brand name GAMMAGARD LIQUID
Common or Proper name GAMMAGARD LIQUID, Immunoglobulin Intravenous
Company Name SHIRE PHARMA CANADA ULC
Market Status MARKETED
Active Ingredient(s) IMMUNOGLOBULIN
Strength(s) 10%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, and 30g/ 300mL
ATC code J06BA
ATC description IMMUNOGLOBULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-07-31
Actual start date 2019-07-31
Estimated end date 2019-09-30
Actual end date 2020-01-13
Shortage status Resolved
Updated date 2020-02-06
Company comments Temporary shortage in some product size formats. Resolved as of 13Jan2020
Health Canada comments
Contact Address 22 ADELAIDE ST WEST, SUITE 3800
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2020-02-06 French Compare
v22 2020-02-06 English Compare
v21 2020-01-13 French Compare
v20 2020-01-13 English Compare
v19 2020-01-13 French Compare
v18 2020-01-13 English Compare
v17 2019-08-23 French Compare
v16 2019-08-23 English Compare
v15 2019-08-23 French Compare
v14 2019-08-23 English Compare
v13 2019-08-23 English Compare
v12 2019-08-01 French Compare
v11 2019-08-01 English Compare
v10 2019-08-01 French Compare
v9 2019-08-01 English Compare
v8 2019-08-01 English Compare
v7 2019-07-31 French Compare
v6 2019-07-31 French Compare
v5 2019-07-31 English Compare
v4 2019-07-31 French Compare

Showing 1 to 20 of 23